Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.
- DOI
- 10.64898/2026.09.17.26363341
- Published
- 2026 Sep 20
- Container
- medRxiv : the preprint server for health sciences
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.09.17.26363341,
title = {Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.},
author = {Wu H and Murphy M and Becot C and Fragano AM and Lin EHS and Surapaneni S and Shirvani D and Cimoch C and Merkin R and Cohen S and Williams WW and Emerick K and Kaufman HL and Shalhout SZ},
year = {2026},
journal = {medRxiv : the preprint server for health sciences},
doi = {10.64898/2026.09.17.26363341},
url = {https://doi.org/10.64898/2026.09.17.26363341}
}RIS
TY - JOUR TI - Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma. AU - Wu H AU - Murphy M AU - Becot C AU - Fragano AM AU - Lin EHS AU - Surapaneni S AU - Shirvani D AU - Cimoch C AU - Merkin R AU - Cohen S AU - Williams WW AU - Emerick K AU - Kaufman HL AU - Shalhout SZ PY - 2026 JO - medRxiv : the preprint server for health sciences DO - 10.64898/2026.09.17.26363341 UR - https://doi.org/10.64898/2026.09.17.26363341 ER -
APA
H, W., M, M., C, B., AM, F., EHS, L., S, S., D, S., C, C., R, M., S, C., WW, W., K, E., HL, K., & SZ, S. (2026). Long-Term Efficacy and Allograft Loss after Immune Checkpoint Inhibitor Therapy in Solid Organ Transplant Recipients with Advanced Cutaneous Squamous Cell Carcinoma.. medRxiv : the preprint server for health sciences. https://doi.org/10.64898/2026.09.17.26363341
Source records
- pubmed · retrieved 2026-09-25T08:14:01.940Z